Insmed Incorporated
Clinical trials sponsored by Insmed Incorporated, explained in plain language.
-
New once-daily inhaler aims to boost exercise ability in rare lung disease
Disease control Recruiting nowThis study tests an inhaled medication called treprostinil palmitil taken once daily to see if it helps adults with pulmonary arterial hypertension (PAH) walk farther. PAH is a serious condition where high blood pressure in the lungs makes it hard to breathe and exercise. The tri…
Phase: PHASE3 • Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Jun 22, 2026 12:09 UTC
-
Lifeline for lung patients: TPIP access extended
Disease control AVAILABLEThis study offers continued access to the inhaled drug TPIP for people with pulmonary arterial hypertension (PAH) or pulmonary hypertension linked to interstitial lung disease (PH-ILD) who have already completed a related study. Participants must have successfully finished prior …
Sponsor: Insmed Incorporated • Aim: Disease control
Last updated Jun 08, 2026 13:12 UTC